| Gene symbol | TNF | Synonyms | DIF, TNF-alpha, TNFA, TNFSF2, TNLG1F | Type of gene | protein-coding |
| Chromosome | 6 | Map location | 6p21.33 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | tumor necrosis factor | ||||
| GTO ID | GTC1286 |
| Trial ID | NCT00617032 |
| Disease | Rheumatoid Arthritis |
| Altered gene | TNF |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | tgAAC94 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Phase 1 Dose Escalation Study of Intra-Articular Administration of tgAAC94, a Recombinant Adeno-Associated Vector Containing the TNFR:Fc Fusion Gene, in Inflammatory Arthritis |
| Year | 2008 |
| Country | Canada|United States |
| Company sponsor | Targeted Genetics Corporation |
| Other ID(s) | 13E04|RAC Protocol # 0307-588|HPB 0088676 |
| Vector information | |||||||||
|
|||||||||
| Cohort1: dose level 1 | |||||||||
|
|||||||||
| Cohort2: dose level 2 | |||||||||
|
|||||||||